Skip to main content
ArticleOPEN ACCESS

Cardiovascular benefit in the limelight: Shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease

Cardiovascular Diabetology
DOI: 10.1186/s12933-018-0760-6
7Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Shehadeh, N., Raz, I., & Nakhleh, A. (2018, August 22). Cardiovascular benefit in the limelight: Shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease. Cardiovascular Diabetology. BioMed Central Ltd. https://doi.org/10.1186/s12933-018-0760-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free